()
 
 

Overview

EpiCept is focused on unmet needs in the treatment of pain and cancer. EpiCept has a staged portfolio of pharmaceutical product candidates with several pain therapies in late-stage clinical trials, and a lead oncology compound (for acute myeloid leukemia, or AML) with demonstrated efficacy in a Phase III trial; a marketing authorization application for this compound has been submitted in Europe. EpiCept is based in Tarrytown, N.Y., and its research and development team in San Diego is pursuing a drug discovery program focused on novel approaches to apoptosis.


Contact Information

777 Old Saw Mill River Road
Tarrytown, NY 10591

tel: 914-606-3500
fax: 914-606-3501
http://www.epicept.com

,  



Investor Relations



tel:
fax:




Stock

Exchange: NASDAQ
Industry: Diagnostic Substances
Market Cap: $21M




 
The information provided here has been obtained from publicly available sources as well as directly from issuers in some cases. Please see our Disclaimer and Terms of Service for more information.